Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in Polypharmacy Patients.

ABSTRACT:

Background

In polypharmacy patients, medication therapy management (MTM) services provide a comprehensive review of current medications and future treatment goals. Pharmacogenetics (PGx) may further optimize the identification of potential drug therapy problems (DTPs); however, the clinical utility of PGx information with a clinical decision support tool (CDST) in an MTM setting in identifying DTPs has not been systematically assessed.

Objective

To assess the clinical utility of an MTM service enhanced by pharmacogenetic test results and a clinical decision support tool.

Methods

This study was a post hoc analysis of the data obtained from an open-label, randomized, observational trial. Polypharmacy patients eligible for MTM service were randomly assigned to 3 interven

SUBMITTER: Kim K 

PROVIDER: S-EPMC10397798 | biostudies-literature | 2018 Dec

REPOSITORIES: biostudies-literature